Info
Finerenone
參考➡️ Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and type 2 diabetes